Cargando…

Invariant natural killer T cells recognize lipid self-antigen induced by microbial danger signals

Invariant natural killer T cells (iNKT cells) play a prominent role during infection and other inflammatory processes, and these cells can be activated through their T cell receptors by microbial lipid antigens. However, increasing evidence shows that they are also activated in situations where no f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brennan, Patrick J., Tatituri, Raju V.V., Brigl, Manfred, Kim, Edy Y., Tuli, Amit, Sanderson, Joseph P., Gadola, Stephan D., Hsu, Fong-Fu, Besra, Gurdyal S., Brenner, Michael B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2011
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3242449/ https://www.ncbi.nlm.nih.gov/pubmed/22037601 http://dx.doi.org/10.1038/ni.2143

Ejemplares similares

Innate and cytokine-driven signals, rather than microbial antigens, dominate in natural killer T cell activation during microbial infection
por: Brigl, Manfred, et al.
Publicado: (2011)

Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseases
por: Gadola, Stephan D., et al.
Publicado: (2006)

Regulation of CD1 Antigen-presenting Complex Stability
por: Odyniec, Artur N., et al.
Publicado: (2010)

Synthesis and biological activity of α-galactosyl ceramide KRN7000 and galactosyl (α1→2) galactosyl ceramide
por: Veerapen, Natacha, et al.
Publicado: (2009)

A humanized mouse model for in vivo evaluation of invariant Natural Killer T cell responses
por: Saavedra-Avila, Noemi Alejandra, et al.
Publicado: (2022)

Identification of distinct human invariant natural killer T-cell response phenotypes to alpha-galactosylceramide
por: Croudace, Joanne E, et al.
Publicado: (2008)

Identification of an α(1→6) mannopyranosyltransferase (MptA), involved in Corynebacterium glutamicum lipomanann biosynthesis, and identification of its orthologue in Mycobacterium tuberculosis
por: Mishra, Arun K, et al.
Publicado: (2007)

Invariant NKT cells recognize glycolipids from pathogenic Gram-positive bacteria
por: Kinjo, Yuki, et al.
Publicado: (2011)

Lysosomal Trafficking, Antigen Presentation, and Microbial Killing Are Controlled by the Arf-like GTPase Arl8b
por: Garg, Salil, et al.
Publicado: (2011)

Sterile activation of invariant natural killer T cells by ER-stressed antigen-presenting cells
por: Bedard, Melissa, et al.
Publicado: (2019)

Dendritic Cells as Danger-Recognizing Biosensors
por: Gi, Mia, et al.
Publicado: (2009)

Lipoproteins act as vehicles for lipid antigen delivery and activation of invariant natural killer T cells
por: Engelen, Suzanne E., et al.
Publicado: (2023)

Activated invariant natural killer T cells directly recognize leukemia cells in a CD1d‐independent manner
por: Aoki, Takahiro, et al.
Publicado: (2020)

Structural characterization of a partially arabinosylated lipoarabinomannan variant isolated from a Corynebacterium glutamicum ubiA mutant
por: Tatituri, Raju Venkata Veera, et al.
Publicado: (2007)

Mouse and Human CD1d-Self-Lipid Complexes Are Recognized Differently by Murine Invariant Natural Killer T Cell Receptors
por: Guo, Tingxi, et al.
Publicado: (2016)

CD169(+) MACROPHAGES PRESENT LIPID ANTIGENS TO MEDIATE EARLY ACTIVATION OF INVARIANT NKT CELLS IN LYMPH NODES
por: Barral, Patricia, et al.
Publicado: (2010)

Invariant Natural Killer T and Mucosal-Associated Invariant T Cells in Asthmatic Patients
por: Lezmi, Guillaume, et al.
Publicado: (2018)

Gram-Positive Bacterial Lipoglycans Based on a Glycosylated Diacylglycerol Lipid Anchor Are Microbe-Associated Molecular Patterns Recognized by TLR2
por: Blanc, Landry, et al.
Publicado: (2013)

Glucosylceramide Synthase Is Involved in Development of Invariant Natural Killer T Cells
por: Popovic, Zoran V., et al.
Publicado: (2017)

Activation of invariant natural killer T cells stimulated with microbial α-mannosyl glycolipids
por: Shimamura, Michio, et al.
Publicado: (2017)

Antitumor Responses of Invariant Natural Killer T Cells
por: Altman, Jennie B., et al.
Publicado: (2015)

Immunometabolic Activation of Invariant Natural Killer T Cells
por: Ververs, Francesca A., et al.
Publicado: (2018)

Antigen specificity of invariant natural killer T-cells
por: Birkholz, Alysia M., et al.
Publicado: (2015)

The two faces of invariant natural killer T cells
por: Walton, Emma L.
Publicado: (2015)

Metabolism in Invariant Natural Killer T Cells: An Overview
por: Yarosz, Emily L., et al.
Publicado: (2021)

Invariant natural killer T cells in lung diseases
por: Jeong, Dongjin, et al.
Publicado: (2023)

Atheroembolic kidney disease: The under‐recognized silent killer
por: Ștefan, Gabriel, et al.
Publicado: (2021)

Invariant NKT cells: Killers and conspirators against cancer
por: Bassiri, Hamid, et al.
Publicado: (2013)

Lineage Differentiation Program of Invariant Natural Killer T Cells
por: Kwon, Dong-il, et al.
Publicado: (2017)

Therapeutic Potential of Invariant Natural Killer T Cells in Autoimmunity
por: Van Kaer, Luc, et al.
Publicado: (2018)

Insights Into Mucosal-Associated Invariant T Cell Biology From Studies of Invariant Natural Killer T Cells
por: Garner, Lucy C., et al.
Publicado: (2018)

Shared and distinct transcriptional programs underlie the hybrid nature of iNKT cells
por: Cohen, Nadia R., et al.
Publicado: (2012)

Innate Invariant NKT Cells Recognize Mycobacterium tuberculosis–Infected Macrophages, Produce Interferon-γ, and Kill Intracellular Bacteria
por: Sada-Ovalle, Isabel, et al.
Publicado: (2008)

Harnessing the Power of Invariant Natural Killer T Cells in Cancer Immunotherapy
por: Bedard, Melissa, et al.
Publicado: (2017)

Harnessing invariant natural killer T cells to control pathological inflammation
por: Bharadwaj, Nikhila S., et al.
Publicado: (2022)

Mycobacterial cell wall biosynthesis: a multifaceted antibiotic target
por: ABRAHAMS, KATHERINE A., et al.
Publicado: (2018)

Synthesis and recycling of the mycobacterial cell envelope
por: Abrahams, Katherine A, et al.
Publicado: (2021)

Mycobacterial drug discovery
por: Abrahams, Katherine A., et al.
Publicado: (2020)

The role of triacylglycerols and repurposing DGAT1 inhibitors for the treatment of Mycobacterium tuberculosis
por: Moorey, Alice R., et al.
Publicado: (2022)

The Extended Family of CD1d-Restricted NKT Cells: Sifting through a Mixed Bag of TCRs, Antigens, and Functions
por: Macho-Fernandez, Elodie, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_kpovo4hf2ap1vvop8oo0mvmu44